Watch IMF chief Kristalina Georgieva and Citigroup CEO Jane Fraser discuss the global economy

[The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]

Spiraling food and energy prices are squeezing households around the world, while central banks are tightening monetary policy to rein in inflation, exerting further pressure on indebted nations, companies and families.

CNBC’s Geoff Cutmore speaks with a panel of top global leaders — Kristalina Georgieva, managing director of the IMF, François Villeroy de Galhau, governor of the Bank of France, Jane Fraser, CEO of Citi, and David Rubenstein, co-founder and co-chairman at Carlyle — to discuss the headwinds and tailwinds facing the global economy and what mix of policies are needed in this new volatile context.

Subscribe to CNBC on YouTube.

Source

Coinbase joining S&P 500 days after bitcoin soared past 0,000

Finance

Coinbase joining S&P 500 days after bitcoin soared past $100,000

May 12, 2025

Key Points Coinbase is joining the S&P 500, replacing Discover Financial, which is being acquired. Shares of the crypto exchange soared in extended trading after the announcement. Bitcoin eclipsed the $100,000 market last week, approaching its record reached in January. Source

Finance

After UK and China trade deals, tariff rate still highest since 1934, Yale report says

May 12, 2025

Key Points The average effective tariff rate on imports is 17.8%, the highest since 1934, even after trade deals reached with China and the U.K. in recent days, according to the Yale Budget Lab. Levies that President Trump placed on other products and countries still remain, including a 10% tariff on almost all trading partners. […]

Finance

Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more

May 12, 2025

Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, […]